Honokiol, a SIRT3 agonist, has the potential to improve implant osseointegration in patients with diabetes, because it might help to reverse the negative effects of diabetes on bone repair (Huang et al., 2022). The gene discussed is SIRT3; the disease is diabetes mellitus.